AlphaCentric Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320K Buy
+1,310
New +$305K 0.32% 98
2024
Q4
$2.63M Buy
+18,176
New +$2.82M 2.62% 3
2023
Q4
Sell
-1,426
Closed -$222K 265
2023
Q3
$222K Sell
1,426
-45
-3% -$7.42K 0.13% 134
2023
Q2
$243K Sell
1,471
-106
-7% -$17.1K 0.14% 127
2023
Q1
$244K Sell
1,577
-19
-1% -$3.07K 0.17% 130
2022
Q4
$282K Buy
+1,596
New +$276K 0.28% 103

Other funds holding JNJ

AlphaCentric Advisors's JNJ Position: Q1 2026 in Review

AlphaCentric Advisors opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 1,310 shares worth $320K. The stake represents 0.32% of the portfolio and ranks #98 among its holdings. This is a return to the name: AlphaCentric Advisors previously reported a position in JNJ as recently as Q4 2024.

AlphaCentric Advisors first reported a position in JNJ in Q4 2022 and has held it in 6 quarters since. The position peaked at $2.63M in Q4 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • AlphaCentric Advisors held 1,310 shares of Johnson & Johnson worth $320K as of Q1 2026.
  • Johnson & Johnson was a new AlphaCentric Advisors position in Q1 2026.
  • Johnson & Johnson made up 0.32% of AlphaCentric Advisors's portfolio in Q1 2026, its #98 holding.
  • AlphaCentric Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 6 quarters since.
  • AlphaCentric Advisors's Johnson & Johnson position peaked at $2.63M in Q4 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.